“…- For the clinical symptoms and signs,[2155354] three of the four items need to be satisfied: (1) young adults or adults onset; (2) acute or subacute onset; (3) headache as the initial symptom; (4) the severity of the disease is consistent with neuroimaging findings (for some infectious diseases, the clinical symptoms and signs are more obvious than neuroimaging findings, while the glioma is the opposite).
- For laboratory workups,[2] three of the five items need to be satisfied: (1) normal or mild elevation of intracranial pressure (usually ≤240 mmH 2 O); (2) normal or mildly elevated cell count (usually ≤50/mm 3 ); (3) normal or mildly to moderately elevated protein in CSF (usually ≤10,000 mg/L); (4) positive CSF-OB and/or elevated MBP; (5) positive serum AQP4.
- For neuroimaging,[271526] one of the following two items needs to be satisfied: (1) multiple foci, but not miliary, two hemispheres involved; (2) clear margin of the lesion (sometimes hypointense margin on T2WI).
- Dynamics of the lesions on contrast-enhanced MRI develop in different clinical stages (≤3 weeks, 4–6 weeks, and >7 weeks):[28] the same lesion shows “nodular”- or “patchy”- to “circular”- (“open-ring-shaped,” “rosette-shaped,” “flame-shaped”) shaped enhancement, and then the enhancement reduced gradually.
- Lesion with “ring”-shaped enhancement in morphology is detected on contrast-enhanced MRI,[21725545556] with the following features: the “ring” is not continuous, with one or multiple openings, and thus showing “open-ring”-, “C”- or inverse “C”-shaped enhancement.
- Positive “comb” sign: “comb”-shaped dilated venules within the paraventricular lesions on contrast-enhanced MRI. [225]
…”